Authors: Anna Howard, Julia Kerr, Monica McLain, Jessie Modlin

Oral chemotherapy agents are being prescribed more frequently in many cancer types. In-office dispensing of oral chemotherapy agents has demonstrated clinical benefits and also shown financial benefit to third-party payers. A previous publication estimated over $200,000 in cost savings annually from in-office dispensing solely from medications returned to stock for credit. However, pharmacists in the in-office setting perform many other interventions that may affect financial outcomes. Read More.

Read More
image-title

American Journal of Managed Care – A generation ago, doctors made decisions, and everyone else adapted. The rise of patient-centered care has changed the game, making medicine a team effort, in which the physician collaborates with nurses, social workers, nutritionists, and other specialists. Most of all, physicians seek input from patients themselves. This is especially true in cancer care, where the advances have never been greater.  Read More

Read More
image-title

The American Journal of Managed Care > April 2018  – Oral anticancer medications are frequently used to treat patients with cancer. We found significant time and energy burdens for clinic staff and patients in obtaining these drugs. …. As payers and healthcare providers examine methods for quality improvement, they should consider improved processes to facilitate prompt initiation of OAMs.   Read More

Read More